69 related articles for article (PubMed ID: 34621669)
1. Identification of Gender-Specific Molecular Differences in Glioblastoma (GBM) and Low-Grade Glioma (LGG) by the Analysis of Large Transcriptomic and Epigenomic Datasets.
Khan MT; Prajapati B; Lakhina S; Sharma M; Prajapati S; Chosdol K; Sinha S
Front Oncol; 2021; 11():699594. PubMed ID: 34621669
[TBL] [Abstract][Full Text] [Related]
2. Comparative Analysis of the GNAI Family Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies.
Raza A; Yen MC; Anuraga G; Shahzadi I; Mazhar MW; Ta HDK; Xuan DTM; Dey S; Kumar S; Santoso AW; William BT; Wang CY
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894479
[TBL] [Abstract][Full Text] [Related]
3. DeepAutoGlioma: a deep learning autoencoder-based multi-omics data integration and classification tools for glioma subtyping.
Munquad S; Das AB
BioData Min; 2023 Nov; 16(1):32. PubMed ID: 37968655
[TBL] [Abstract][Full Text] [Related]
4. Study of the Female Sex Survival Advantage in Melanoma-A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts.
Emran AA; Nsengimana J; Punnia-Moorthy G; Schmitz U; Gallagher SJ; Newton-Bishop J; Tiffen JC; Hersey P
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32731355
[TBL] [Abstract][Full Text] [Related]
5. MR1 overexpression correlates with poor clinical prognosis in glioma patients.
Kubica P; Lara-Velazquez M; Bam M; Siraj S; Ong I; Liu P; Priya R; Salamat S; Brutkiewicz RR; Dey M
Neurooncol Adv; 2021; 3(1):vdab034. PubMed ID: 33948562
[TBL] [Abstract][Full Text] [Related]
6. Integration of Multi-Omics Data for the Classification of Glioma Types and Identification of Novel Biomarkers.
Vieira FG; Bispo R; Lopes MB
Bioinform Biol Insights; 2024; 18():11779322241249563. PubMed ID: 38812741
[TBL] [Abstract][Full Text] [Related]
7. Glioma Grading Using Cell Nuclei Morphologic Features in Digital Pathology Images.
Reza SM; Iftekharuddin KM
Proc SPIE Int Soc Opt Eng; 2016 Feb; 9785():. PubMed ID: 27942094
[TBL] [Abstract][Full Text] [Related]
8. Strength of spatial correlation between structural brain network connectivity and brain-wide patterns of proto-oncogene and neural network construction gene expression is associated with diffuse glioma survival.
Kesler SR; Harrison RA; Schultz AT; Michener H; Bean P; Vallone V; Prinsloo S
medRxiv; 2023 Nov; ():. PubMed ID: 38076940
[TBL] [Abstract][Full Text] [Related]
9. Strength of spatial correlation between gray matter connectivity and patterns of proto-oncogene and neural network construction gene expression is associated with diffuse glioma survival.
Kesler SR; Harrison RA; Schutz AT; Michener H; Bean P; Vallone V; Prinsloo S
Front Neurol; 2024; 15():1345520. PubMed ID: 38601343
[TBL] [Abstract][Full Text] [Related]
10. A first comprehensive analysis of Transcribed Ultra Conserved Regions uncovers important regulatory functions of novel non-coding transcripts in gliomas.
Gibert MK; Zhang Y; Saha S; Marcinkiewicz P; Dube C; Hudson K; Sun Y; Bednarek S; Chagari B; Sarkar A; Roig-Laboy C; Neace N; Saoud K; Setiady I; Hanif F; Schiff D; Kumar P; Kefas B; Hafner M; Abounader R
Res Sq; 2024 Apr; ():. PubMed ID: 38699302
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of diffusion kurtosis imaging and diffusion tensor imaging in detecting corticospinal tract impairment in diffuse glioma patients.
Liu X; Zeng S; Tao T; Yang Z; Wu X; Zhao J; Zhang N
Neuroradiology; 2024 May; 66(5):785-796. PubMed ID: 38478062
[TBL] [Abstract][Full Text] [Related]
12. Sex-specific molecular differences in glioblastoma: assessing the clinical significance of genetic variants.
Jovanovich N; Habib A; Chilukuri A; Hameed NUF; Deng H; Shanahan R; Head JR; Zinn PO
Front Oncol; 2023; 13():1340386. PubMed ID: 38322284
[TBL] [Abstract][Full Text] [Related]
13. Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods.
Martins S; Coletti R; Lopes MB
BioData Min; 2023 Sep; 16(1):26. PubMed ID: 37752578
[TBL] [Abstract][Full Text] [Related]
14. Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.
Huang J; Fu X; Xue Q; Ma P; Yin Y; Jiang M; Lu Y; Ying Q; Jiang J; He H; Wu D
Dis Markers; 2023; 2023():7146589. PubMed ID: 36852158
[TBL] [Abstract][Full Text] [Related]
15. A survival nomogram model constructed with common clinical characteristics to assist clinical decisions for diffuse low-grade gliomas: A population analysis based on SEER database.
Ao L; Shi D; Liu D; Yu H; Xu L; Xia Y; Hao S; Yang Y; Zhong W; Zhou J; Xia H
Front Oncol; 2023; 13():963688. PubMed ID: 36845716
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Impact of Gender, Therapeutic Strategies, Molecular Background, and Tumor-Infiltrating Lymphocytes in Glioblastoma: A Still Unsolved Jigsaw.
Innocenti L; Ortenzi V; Scarpitta R; Montemurro N; Pasqualetti F; Asseri R; Lazzi S; Szumera-Cieckiewicz A; De Ieso K; Perrini P; Naccarato AG; Scatena C; Fanelli GN
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833428
[TBL] [Abstract][Full Text] [Related]
17. Cost Matrix of Molecular Pathology in Glioma-Towards AI-Driven Rational Molecular Testing and Precision Care for the Future.
Jagasia S; Tasci E; Zhuge Y; Camphausen K; Krauze AV
Biomedicines; 2022 Nov; 10(12):. PubMed ID: 36551786
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Factors of Low-Grade Gliomas in Adults.
Deacu M; Popescu S; Docu Axelerad A; Topliceanu TS; Aschie M; Bosoteanu M; Cozaru GC; Cretu AM; Voda RI; Orasanu CI
Curr Oncol; 2022 Sep; 29(10):7327-7342. PubMed ID: 36290853
[TBL] [Abstract][Full Text] [Related]
19. Identification of Gender- and Subtype-Specific Gene Expression Associated with Patient Survival in Low-Grade and Anaplastic Glioma in Connection with Steroid Signaling.
Hirtz A; Lebourdais N; Thomassin M; Rech F; Dumond H; Dubois-Pot-Schneider H
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077653
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
